View Older Stories View More Recent Stories

Apr 7, 2021 07:00AM Applied DNA and Northwell Health Establish SARS-CoV-2 Mutation and Variant Tracking Program
Apr 1, 2021 08:00AM Applied DNA Appoints Clay Shorrock as Chief Legal Officer and Executive Director of Business Development
Mar 11, 2021 08:35AM Applied DNA Sciences (APDN) Receives Blanket Purchase Order for Linea COVID-19 Assay Kits for 10,000 Tests
Mar 11, 2021 08:30AM Applied DNA Receives Blanket Purchase Order for Linea™ COVID-19 Assay Kits for 10,000 Tests
Mar 9, 2021 09:55AM Applied DNA Launches Linea™ COVID-19 Selective Genomic Surveillance™ Mutation Panel to Boost SARS-CoV-2 Variant Detection and Tracking Nationally
Mar 8, 2021 10:49AM Applied DNA to Participate in Upcoming Conferences
Mar 2, 2021 07:00AM Applied DNA and Evvivax Initiate Phase I of Clinical Trial to Evaluate LinearDNA™ COVID-19 Vaccine Candidate for Feline Veterinary Market
Feb 25, 2021 09:06AM Applied DNA Sciences (APDN) Granted U.S. Patent Covering Methods of Utilizing DNA Tagged Submicron Particles for Authentication
Feb 25, 2021 09:00AM Applied DNA Granted U.S. Patent Covering Methods of Utilizing DNA Tagged Submicron Particles for Authentication
Feb 19, 2021 08:07AM Applied DNA Sciences (APDN) to Provide Back-To-Campus COVID-19 Surveillance Testing to LIM College
Feb 19, 2021 08:00AM Applied DNA to Provide Back-To-Campus COVID-19 Surveillance Testing to LIM College
Feb 11, 2021 04:05PM Applied DNA Reports First Fiscal Quarter 2021 Revenues at Upper End of Guided Range
Feb 11, 2021 07:00AM Applied DNA and Cytocheck Detect First Instance of SARS-CoV-2 B.1.1.7 Variant in Kansas
Feb 5, 2021 07:00AM Applied DNA Schedules Fiscal 2021 First Quarter Financial Results Conference Call and Webcast for Thursday, February 11, 2021
Feb 2, 2021 10:00AM Applied DNA Achieves Program Milestone in Development of Linear DNA Veterinary COVID-19 Vaccine
Jan 26, 2021 09:41AM TruTrace Technologies™ and Applied DNA Unveil Complete Cannabis Product Validation and Authentication Solution
Jan 26, 2021 08:00AM Applied DNA and TruTrace Technologies™ Unveil Complete Cannabis Product Validation and Authentication Solution
Jan 20, 2021 07:05AM Applied DNA Sciences (APDN) Announces Promotion of Judith Murrah to Chief Operating Officer Position
Jan 20, 2021 07:00AM Applied DNA Promotes Judith Murrah to Chief Operating Officer
Jan 19, 2021 07:00AM Applied DNA Linea™ COVID-19 Assay Kit Demonstrates Effectiveness with Detection of Multiple SARS-CoV-2 Variants During Recent Surveillance Testing
Jan 15, 2021 07:02AM Applied DNA Sciences (APDN) Reports Business Update on COVID-19 Diagnostics and Testing
Jan 15, 2021 07:00AM Applied DNA Provides Business Update on COVID-19 Diagnostics and Testing
Jan 13, 2021 11:44AM Applied DNA Announces Closing of $15 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
Jan 11, 2021 07:08AM Applied DNA Sciences (APDN) Prices 1.81M Share Registered Direct Offering at $8.30/Sh
Jan 11, 2021 07:00AM Applied DNA Announces Pricing of $15 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
Jan 8, 2021 01:45PM Applied DNA Sciences (APDN) Notes FDA Lists its COVID-19 Assay Kit as 1 of Only 2 Able to Detect U.K. Variant
Jan 8, 2021 01:43PM U.S. FDA Lists Applied DNA’s Linea™ COVID-19 Assay Kit as 1 of Only 2 EUA-Authorized Tests Able to Detect S-Gene Mutation Found in SARS-CoV-2 U.K. Variant (B.1.1.7)
Jan 5, 2021 08:00AM Applied DNA to Participate in the H.C. Wainwright BIOCONNECT 2021 Conference
Jan 4, 2021 08:00AM Applied DNA Announces Preliminary Estimated First Fiscal Quarter 2021 Revenues in the Range of $1.3 Million to $1.6 Million
Dec 29, 2020 08:02AM Applied DNA Sciences (APDN) Announces Partnership with CLEARED4 on Pooled COVID-19 Surveillance Testing Program
Dec 29, 2020 08:00AM Applied DNA Partners with CLEARED4 on Pooled COVID-19 Surveillance Testing Program
Dec 17, 2020 04:05PM Applied DNA Reports 2020 Year End and Fiscal Fourth Quarter Financial Results
Dec 17, 2020 01:10PM Applied DNA Awarded Pooled Surveillance Testing Contract Valued at Up to $2.0 Million from Suffolk County (N.Y.) Government
Dec 11, 2020 08:00AM Compliance with New York State Winter COVID-19 Plan Drives Demand for Applied DNA’s Pooled Surveillance Testing Program
Dec 8, 2020 09:00AM Applied DNA Schedules Fiscal 2020 Fourth Quarter Financial Results Conference Call for Thursday, December 17, 2020 at 4:30 PM EST
Dec 7, 2020 08:00AM Nutrition21 Transitions to Applied DNA’s CertainT® Platform to Secure IP-protected Portfolio of Dietary Supplement Ingredients
Dec 1, 2020 08:00AM Applied DNA to Provide COVID-19 Surveillance Testing to Stony Brook Basketball
Nov 30, 2020 07:07AM Applied DNA Sciences (APDN) EvviVax, and GVS Receive Regulatory Approval to Conduct Veterinary Clinical Trial for Linear COVID-19 Vaccine Candidate
Nov 30, 2020 07:00AM Applied DNA, EvviVax, and GVS Receive Regulatory Approval to Conduct Veterinary Clinical Trial for Linear COVID-19 Vaccine Candidate
Nov 27, 2020 10:39AM Applied DNA to Present at the Imperial Capital 2020 Security Investor Conference on December 3
Nov 25, 2020 08:02AM Applied DNA Sciences (APDN) Reports Successful Amendment to FDA EUA Significantly Expands Addressable Market for Linea COVID-19 Assay Kit
Nov 25, 2020 08:00AM Applied DNA Significantly Expands Addressable Market for Linea™ COVID-19 Assay Kit via Successful Amendment to FDA EUA
Nov 12, 2020 08:00AM Applied DNA Secures Blanket Purchase Order for 10,000 Linea™ COVID-19 Tests
Nov 10, 2020 07:00AM Stony Brook University Hospital Launches COVID-19 Surveillance Testing Program Powered by Applied DNA’s Assay Kit and Services
Nov 2, 2020 08:00AM Applied DNA Announces Linear DNA Orders from New Contract Research Customers for Use in RNA Vaccine and Adeno-Associated Virus Applications
Oct 30, 2020 08:00AM Applied DNA to Increase COVID-19 Surveillance Testing Utility for its Linea™ COVID-19 Assay Kits Through Expanded Use of Robotic Automation
Oct 12, 2020 07:30AM Applied DNA Secures $1.0+ Million in COVID-19 Surveillance Testing Annualized Revenue, Builds Sales Pipeline for Test Kit and Testing-as-a-Service
Oct 8, 2020 09:00AM Applied DNA Announces Repayment of Secured Convertible Notes
Sep 29, 2020 09:40AM Applied DNA Signs Master Services Agreement with Stony Brook University Hospital for COVID-19 Diagnostic Assay Kit and Automated Systems, Receives Initial Purchase Order
Sep 21, 2020 08:37AM Applied DNA Sciences (APDN) Enters Supply Agreement with ITW Pillar Technologies to Bring CertainT Platform to Textiles Including Those Used in Personal Protective Equipment
View More Recent Stories View Older Stories